The global tomosynthesis market had a valuation of USD 1.2 billion in 2022 and is projected to reach USD 3.6 billion by 2032, with a compound annual growth rate (CAGR) of 12.5% during the forecast period. The market growth is primarily fueled by key factors such as the increasing prevalence of breast cancer, the aging population, and advancements in medical imaging technology. Breast cancer is a leading cause of death among women worldwide, and its incidence is rising due to various factors such as exposure to radiation, sedentary lifestyles, and unhealthy eating habits. Tomosynthesis, a crucial technique for breast cancer detection, provides three-dimensional imaging that enables more precise diagnosis. Consequently, the growing incidence of breast cancer is expected to drive the revenue growth of the tomosynthesis market.

Furthermore, the market is significantly influenced by the aging population. The elderly are more susceptible to various chronic diseases, including cancer. In the coming years, the senior population is expected to experience substantial growth, resulting in a significant rise in the demand for tomosynthesis and other medical imaging techniques. Moreover, advancements in medical imaging technology contribute to the market's revenue growth. The advent of digital tomosynthesis has revolutionized medical imaging by providing enhanced image accuracy and quality. With the development of three-dimensional imaging, healthcare professionals can now diagnose breast cancer more accurately, reducing the risk of false-positive results and unnecessary biopsies.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/2373

Major Companies and Competitive Landscape:

Some of the major players in the global tomosynthesis market are:

• General Electric Company
• Hologic, Inc.
• Siemens Healthineers AG
• FujiFilm Holdings Corporation
• Koninklijke Philips N.V.
• Toshiba Corporation
• Planmed Oy
• Fujifilm Medical Systems U.S.A., Inc.
• GE Healthcare
• Agfa-Gevaert Group
• Analogic Corporation

To know more about the report @ https://www.reportsanddata.com/report-detail/tomosynthesis-market

Driving Factors:

1. Rising Prevalence of Breast Cancer: The increasing incidence of breast cancer globally is a major driving factor for the tomosynthesis market. As breast cancer becomes more common due to various factors such as radiation exposure, sedentary lifestyles, and poor dietary habits, the demand for accurate diagnostic techniques like tomosynthesis rises.
2. Aging Population: The aging population is another significant driving factor for the tomosynthesis market. Elderly individuals are more susceptible to chronic diseases, including cancer. With the projected growth of the senior population in the coming years, there will be a greater need for tomosynthesis and other medical imaging techniques for early detection and diagnosis.
3. Technological Advancements in Medical Imaging: The continuous development and advancements in medical imaging technology contribute to the growth of the tomosynthesis market. Innovations such as digital tomosynthesis and three-dimensional imaging have improved image accuracy and quality, enabling healthcare professionals to diagnose breast cancer more precisely. This reduces the risk of false-positive results and unnecessary biopsies, driving the adoption of tomosynthesis.

Restraints:

1. High Cost: One of the primary restraints for the tomosynthesis market is the high cost associated with the equipment and procedures. Tomosynthesis systems are relatively expensive, making it challenging for healthcare facilities, especially in developing regions, to afford and adopt this technology.
2. Limited Reimbursement Policies: The lack of comprehensive reimbursement policies for tomosynthesis procedures poses a restraint to market growth. In some healthcare systems, reimbursement coverage for tomosynthesis may be limited or not adequately provided, making it less accessible for patients and healthcare providers.
3. Regulatory Hurdles: Compliance with regulatory requirements and obtaining necessary approvals for tomosynthesis systems can be a complex and time-consuming process. Stringent regulations and the need to demonstrate the safety and efficacy of these devices can pose challenges for manufacturers and slow down the market growth.
4. Limited Awareness and Adoption: Despite the benefits of tomosynthesis in breast cancer detection, there may still be limited awareness and adoption of this technology, particularly in certain regions or healthcare settings. Lack of knowledge among patients and healthcare professionals about the advantages of tomosynthesis can hinder its market growth.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2373

The advantages of tomosynthesis in the market can be summarized as follows:

1. Improved Diagnostic Accuracy: Tomosynthesis provides three-dimensional images that offer improved clarity and accuracy compared to traditional two-dimensional imaging techniques. It reduces the overlapping of tissues, which can help radiologists detect and characterize lesions more effectively. This improved accuracy can lead to earlier detection of abnormalities and more accurate diagnoses.
2. Enhanced Detection of Breast Cancer: In breast imaging, tomosynthesis, also known as 3D mammography, has proven to be particularly beneficial. It provides multiple images of the breast from different angles, allowing for a more comprehensive view of breast tissue. This increased sensitivity helps in detecting smaller cancers that may be missed on conventional mammograms, resulting in earlier diagnosis and improved treatment outcomes.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: [email protected]
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs